KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ugi (UGI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ugi (UGI) over the last 17 years, with Q4 2025 value amounting to $221.0 million.

  • Ugi's Capital Expenditures rose 473.93% to $221.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $847.0 million, marking a year-over-year decrease of 47.0%. This contributed to the annual value of $837.0 million for FY2025, which is 515.08% up from last year.
  • According to the latest figures from Q4 2025, Ugi's Capital Expenditures is $221.0 million, which was up 473.93% from $258.0 million recorded in Q3 2025.
  • Over the past 5 years, Ugi's Capital Expenditures peaked at $304.0 million during Q3 2023, and registered a low of $117.0 million during Q1 2021.
  • For the 5-year period, Ugi's Capital Expenditures averaged around $206.8 million, with its median value being $207.5 million (2022).
  • In the last 5 years, Ugi's Capital Expenditures crashed by 2687.5% in 2021 and then skyrocketed by 4444.44% in 2022.
  • Quarter analysis of 5 years shows Ugi's Capital Expenditures stood at $186.0 million in 2021, then grew by 12.9% to $210.0 million in 2022, then decreased by 25.71% to $156.0 million in 2023, then skyrocketed by 35.26% to $211.0 million in 2024, then rose by 4.74% to $221.0 million in 2025.
  • Its last three reported values are $221.0 million in Q4 2025, $258.0 million for Q3 2025, and $222.0 million during Q2 2025.